ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MTPH Midatech Pharma Plc

18.00
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Midatech Pharma Plc LSE:MTPH London Ordinary Share GB00BNGF1L75 ORD GBP0.02
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.00 17.00 19.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Midatech Pharma Share Discussion Threads

Showing 1776 to 1796 of 2250 messages
Chat Pages: Latest  78  77  76  75  74  73  72  71  70  69  68  67  Older
DateSubjectAuthorDiscuss
09/9/2020
09:24
You'll never see these low levels again.
hodhasharon
07/9/2020
10:33
Existing week .I am long and adding
shujja1
07/9/2020
09:44
Yup total nutcase.

Who knows? With this one.

Maybe well get a better idea tomorrow.

escapetohome
07/9/2020
09:38
Ditto. Small size, though. This one is a little mad.
chucko1
07/9/2020
09:15
Im back in
escapetohome
03/9/2020
09:58
MTPH strong buy signal.Big pharma Jv update imminent.We can test 100p again.Great entry price
36jay
30/8/2020
22:07
RNS Number : 6125T

Midatech Pharma PLC

21 July 2020

21 July 2020

Midatech Pharma PLC

("Midatech" or the "Company")

Midatech adds to collaborative business model for the Q-Sphera platform

Midatech Pharma's next generation drug delivery technologies to be applied to new modalities in collaboration with a European pharmaceutical company.

Cardiff, UK, 21 July 2020: Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces it has entered into a research collaboration for the Q-Sphera platform with a European affiliate of a global pharmaceutical company.

Within the multi-project collaboration, Midatech will deploy its in-house expertise and proprietary drug delivery platforms towards assets nominated by the pharmaceutical company.

The feasibility studies may establish the application of the Q-Sphera platform to new modalities in drug delivery. Novel assets and products arising from the collaboration will be the property of the pharmaceutical company and in the event that the feasibility study is successful, the pharmaceutical company would be required to enter into a licence agreement to use the Q-Sphera platform.

Following announcement of the first research agreement for the Q-Sphera platform on 8 June 2020, this second Pharmaceutical collaboration further builds upon Midatech's dual business model to develop an internal portfolio of differentiated, sustained release products in parallel to enabling access to the technology by strategic collaborators to best exploit the full potential of the Q-Sphera platform, and potentially broaden its application to new therapeutic areas and modalities.

Stephen Stamp, CEO of Midatech, said:

"This collaboration with a highly reputable company further builds upon Midatech's mission to use our expertise and established capabilities to continually innovate and improve our technologies. By furthering our collaborative business model, we believe we can enable the unique qualities of this technology to reach beyond our own internal development pipeline for the benefit of all patients."

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014

bidmsa
28/8/2020
11:58
That is a US $Dollar price which has to be converted in to uk £pound price before you
divide it by 5.

bidmsa
28/8/2020
11:33
According to US price we should be around 50p to 55p 1 adr equally 5 uk shares
abconline
28/8/2020
07:58
28 August 2020

Midatech Pharma PLC

("Midatech" or the "Company")

Notice of Interim Results

Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will announce its interim results for the six months ended 30 June 2020 on 10 September 2020.

The Company will host an investor conference call at 2.00pm on the day of the results, details of which will be announced in due course.

eggbird
27/8/2020
13:28
News this afternoon? The RNS pattern has painted itself in the chart.
hodhasharon
27/8/2020
11:10
The RNS from the seller the other day clearly say that the holding is now below 3%. not 100% out as some are saying. This share is still offered.
wilsonst1
26/8/2020
13:36
midatech 1 volume trade now showing on Pre US Market opening.
bidmsa
26/8/2020
12:49
Back to 90p....this is getting boring.
hodhasharon
26/8/2020
12:49
getting rid of the shorters & then let it take off.
bidmsa
26/8/2020
11:47
midatech 1 volume trade news is coming.
bidmsa
25/8/2020
10:26
entering into a research collaboration for the Q-Sphera platform with a European affiliate of a global pharmaceutical company.


regarding to the above which pharmaceutical company is it.

bidmsa
22/8/2020
09:14
Yes there is no way you can deal ‘at best’ on the spike, so i ususally set. A limit order 1 or 2 p below , and it ususally goes through, for say 10,000 shares.
escapetohome
22/8/2020
09:12
Yup a very spiky share, you can be sure i will buy back at 30 - 33 p , should that opportunity become available once more.
escapetohome
Chat Pages: Latest  78  77  76  75  74  73  72  71  70  69  68  67  Older

Your Recent History

Delayed Upgrade Clock